RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program

A modification (3) was made to University of North Carolina puchase order HHSN261201000004I to provide thyroid, papillary cases for The Cancer Genome Atlas (TCGA) Program, NIH, NCI.

DUNS: 608195277

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System code 325413, size standard 500.

An award was made to Miami University School of Medicine in response to the 08/03/10 interim due date, to provide breast tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 052780918

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to Singapore Health Servised in response to the 08/03/10 interim due date, to provide lymphoma tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 894691005

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to University of Nebraska in response to the 08/03/10 interim due date, to provide lymphoma tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 168559177

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to British Columbia Cancer Agency in response to the 08/03/10 interim due date, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 209137736

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to MD Anderson Cancer Center in response to the 07/20/10 interim due date, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 800772139

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to Prince Charles Hospital in response to the 07/20/10 interim due date, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 751800624
This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to University Health Network in response to the 07/20/10 interim due date, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 208469486

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to Ohio State University in response to the 07/20/10 interim due date, to provide thyroid tissue for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 832127323

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

An award was made to Health Research, Inc. DBA Roswell Park in response to the 06/08/10 interim due date, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 824771034

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to Fundacio Privada Clinic per a la Recerca in response to the 08/03/10 due date under RFQ-NCI-10009-AS to provide the following: peripheral blood nucleated cells for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 478584741

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Johns Hopkins University in response to the 7/20/10 due date under RFQ-NCI-10009-AS to provide the following: thyroid tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

The original award HHSN261201000020I was modified to add CLIN 2 for thyroid tissue.

DUNS: 001910777

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Sloan Kettering Cancer Institution in response to the 7/20/10 due date under RFQ-NCI-10009-AS to provide the following: thyroid tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to MD Anderson Cancer Center in response to the 8/3/10 due date under RFQ-NCI-10009-AS to provide the following: thyroid tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

This tissue was added as a modification to HHSN261201000047I. 

DUNS: 800772139

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.  An award was made to Medical College of Georiga in response to the 7/20/10 due date under RFQ-NCI-10009-AS to provide thyroid tissue for The Cancer Genome Atlas Program, National Cancer Institute, National INstitutes of Health.

DUNS:  966668691

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.An award was made to Johns Hopkins University in response to the 7/20/10 due date under RFQ-NCI-10009-AS to provide thyroid tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS:  001910777

 This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

An award was made to Michigan University in response to the 6/29/10 due date under RFQ-NCI-10009-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

An award was made to Sloan Kettering Cancer Institution in response to the 7/6/10 due date under RFQ-NCI-10009-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Cedars Sinai Medica Center in response to the 6/8/10 due date under RFQ-NCI-10009-AS to provide the following: brain tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 075307785

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Ontario Institute for Cancer Research in response to the 5/11/10 due date under RFQ-NCI-10009-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 205540219

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Sloan Kettering Institution for Cancer in response to the 4/22/10 due date under RFQ-NCI-10009-AS to provide the following: colon tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Ontario Institute for Cancer Research in response to the 5/11/10 due date under RFQ-NCI-10009-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 205540219

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Johns Hopkins University in response to the 4/13/10 due date under RFQ-NCI-10009-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS:  001910777

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Pittsburgh University in response to the 12/18/09 due date under RFQ-NCI-10009-AS to provide the following; thyroid papillary carcinoma and thyroid follicular carcinoma tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS:  004514360

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Indivumed Inc. in response to the 12/18/09 due date under RFQ-NCI-10009-AS to provide the following; prostate adenocarcinoma and bladder carcinoma tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 168408347

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

This is a combined synopsis/solicitation for commercial items using simplified acquisition procedures and prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice.

The full text of Request for Quotation (RFQ) RFQ-NCI-10009-AS may be accessed through the National Cancer Institute's (NCI) Office of Acquisitions homepage by using the following internet address - http://rcb.cancer.gov/rcb-internet/index.jsp. (Please click on Current Request for Proposals to access). Only electronic copies of the solicitation are available. It is the offeror's responsibility to monitor the above internet site for the solicitation and any amendments. POTENTIAL OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND AMENDMENTS. No collect calls will be accepted.

This project is funded thorough the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to the reporting requirements of the act.

It is anticipated this solicitation will result in multiple awards.

Awards resulting from this solicitation No. RFQ-NCI-10009-AS will include all applicable provisions and clauses in effect at the time of award for commercial items using simplified procedures.

Under this RFQ, the offeror shall provide clinically annotated biospecimens to TCGA for the following cancer types: Thyroid follicular carcinoma, Thyroid papillary carcinoma, Non-Hodgkins Lymphoma (ex Diffuse large B-cell lymphoma), Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Diffuse large B-cell lymphoma, Other Cancer Types Currently Not Identified.

The NCI is expanding its basic and translational research programs that rely heavily on sufficient availability of high quality well annotated biospecimens suitable for use in genomic studies. The NCI's overarching goal with such programs is to improve the ability to diagnose, treat, and prevent cancer. The Cancer Genome Atlas (TCGA), one such program, is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies. The NCI and the National Human Genome Research Institute (NHGRI) launched TCGA as a 3-year pilot project in 2006, and have since (August 2009) initiated the second phase of the project to study at least 20 additional cancers over 5 years. This project aims to systematically explore the entire spectrum of genomic changes involved in human cancer. Specifically, the project is designed to comprehensively analyze DNA copy number changes, including large (on the order of chromosome segments) and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both tumor tissue and case-matched germline DNA. The suite of analysis platforms will be applied to a common set of molecular analytes obtained from clinically annotated high-quality tumor biospecimens and case-matched normal tissue (control). More detailed information can be found at the project's website: http://cancergenome.nih.gov. To successfully generate comprehensive data in phase two, TCGA will need in excess of 40,000 biospecimens over course of the project.